Ignite Creation Date:
2024-05-06 @ 10:56 AM
Last Modification Date:
2024-10-26 @ 12:37 PM
Study NCT ID:
NCT03381417
Status:
COMPLETED
Last Update Posted:
2018-01-02
First Post:
2017-12-11
Brief Title:
Nanogen Pegcyte Clinical Study for the Prevention of CIN in Breast-cancer Patients
Sponsor:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Organization:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-06
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-06
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-11
First Submit QC Date:
December 17 2017
Study First Post Date:
2017-12-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-28
Last Update Post Date:
2018-01-02
Last Update Post Date Type:
ACTUAL